Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SRF2, a TGF-beta antagonist, available for licensing from NIH

March 14, 2002

Atrix licenses Israeli Eligard marketing rights to Luxembourg

March 13, 2002

Promising preclinical results for Celgene's JNK inhibitors

March 13, 2002

Synthetic peptide sensitizes leukemia cell lines to hyperthermia

March 13, 2002

Remedyne licenses Bayer antigen for use in cancer immunotherapeutic

March 13, 2002

Oncolytics Biotech files IND for clinical trial of Reolysin in recurrent malignant glioma

March 12, 2002

Phase IIa trial of PCK-3145 in prostate cancer cleared by MCA

March 12, 2002

New combination treatment for advanced hepatocellular carcinoma is safe, beneficial

March 12, 2002

Patient enrollment target met in phase II/III trial of Onco TCS in relapsed aggressive NHL

March 12, 2002

Metvix PDT receives marketing authorization in Germany

March 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...